TCI Unveils Promising GLP-1 Formula Clinical Trial Results for Advanced Weight Management

Follow Drugslib on

TAIPEI, Oct. 7, 2024. TCI Co., Ltd. ("TCI"), a global CDMO leader in health and skincare solutions, is pleased to announce the successful results of its recent clinical trial of the GLP-1 Formula, a natural supplement designed to support weight management in adults. The clinical trial, conducted from October 25 to December 31, 2023, demonstrated that the formula was effective in promoting significant weight loss among the 560 participants, who collectively lost a total of 2,732 kg. *

Participants aged 18 to 75 were instructed to take one sachet containing seven tablets of GLP-1 Formula daily before lunch. The trial results revealed an average weight loss of 4.9 kg per participant. Furthermore, over 59.3% of participants successfully lost at least 4 kg of their baseline body weight by the trial's end. These compelling results highlight the potential of the GLP-1 Formula as an effective, natural approach to weight management. *

Developed by TCI, the GLP-1 Formula is designed to enhance the secretion of GLP-1 naturally, a hormone known for regulating appetite and promoting satiety. By using a blend of natural plant extracts, probiotics, and amino acids such as phenylalanine and leucine, the formula effectively stimulates GLP-1 secretion, leading to appetite suppression and weight reduction. *

"Our mission is to provide innovative, effective solutions for health and wellness, and the results of this trial affirm that GLP-1 Formula could play a significant role in supporting weight management," said Chi-Fu Chiang, Head of Research and Design at TCI. "We are excited to offer a product that not only achieves impressive weight loss but also provides a natural alternative for those struggling with weight." *

The success of this trial marks a major milestone for TCI in its ongoing commitment to developing natural, science-backed solutions for addressing global wellness challenges.

About TCI

TCI Co., Ltd. is a global leader in dietary supplements and cosmetics ODM with over 40 years of experience. Operating from seven production sites worldwide, including the US, Japan, China, and Taiwan, with products distributed in 65 countries. TCI's subsidiaries include TCI BIO, MBI, TCI GENE, TCI LIVING, IOPACKAGE, and PETFOOD.

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease. Results may vary.

SOURCE TCI

Posted : 2024-10-08 06:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords